Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
Authors
Keywords
Cholangiocarcinoma, Cholangiocarcinoma Cell, Embryonic Ectoderm Development, Cholangiocarcinoma Cell Line, Lipofectamine Transfection Reagent RNAiMAX
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue S3, Pages 667-675
Publisher
Springer Nature
Online
2013-07-26
DOI
10.1245/s10434-013-3135-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct
- (2012) Motoko Sasaki et al. HISTOPATHOLOGY
- Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts
- (2012) Hirohisa Okabe et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
- (2012) A. Avan et al. MOLECULAR CANCER THERAPEUTICS
- Hepatic Stellate Cells Accelerate the Malignant Behavior of Cholangiocarcinoma Cells
- (2010) Hirohisa Okabe et al. ANNALS OF SURGICAL ONCOLOGY
- Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
- (2010) Wen-Yu Huang et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
- (2010) B. Zhang et al. CARCINOGENESIS
- Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
- (2010) H. Li et al. MOLECULAR CANCER RESEARCH
- Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
- (2009) Junpei Yamaguchi et al. CANCER SCIENCE
- Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
- (2009) Z L Wu et al. CELL DEATH AND DIFFERENTIATION
- Sevelamer Decreases Serum Uric Acid Concentration through Adsorption of Uric Acid in Maintenance Hemodialysis Patients
- (2009) Iwao Ohno et al. INTERNAL MEDICINE
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Anatomy of Polycomb and Trithorax Chromatin Landscapes in Drosophila Embryos
- (2009) Bernd Schuettengruber et al. PLOS BIOLOGY
- Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
- (2008) A. V. Ougolkov et al. CLINICAL CANCER RESEARCH
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
- (2008) Satoshi Fujii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis
- (2008) M Sasaki et al. JOURNAL OF PATHOLOGY
- The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
- (2008) Motoko Sasaki et al. LABORATORY INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started